Literature DB >> 11876642

Atomic resolution (0.98 A) structure of eosinophil-derived neurotoxin.

G Jawahar Swaminathan1, Daniel E Holloway, Kasinadar Veluraja, K Ravi Acharya.   

Abstract

Human eosinophil-derived neurotoxin (EDN) is a small, basic protein that belongs to the ribonuclease A superfamily. EDN displays antiviral activity and causes the neurotoxic Gordon phenomenon when injected into rabbits. Although EDN and ribonuclease A have appreciable structural similarity and a conserved catalytic triad, their peripheral substrate-binding sites are not conserved. The crystal structure of recombinant EDN (rEDN) has been determined at 0.98 A resolution from data collected at a low temperature (100 K). We have refined the crystallographic model of the structure using anisotropic displacement parameters to a conventional R-factor of 0.116. This represents the highest resolution structure of rEDN determined to date and is only the second ribonuclease structure to be determined at a resolution greater than 1.0 A. The structure provides a detailed picture of the conformational freedom at the various subsites of rEDN, and the water structure accounts for more than 50% of the total solvent content of the unit cell. This information will be crucial for the design of tight-binding inhibitors to restrain the ribonucleolytic activity of rEDN.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876642     DOI: 10.1021/bi015911f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  A reinforced merging methodology for mapping unique peptide motifs in members of protein families.

Authors:  Hao-Teng Chang; Tun-Wen Pai; Tan-chi Fan; Bo-Han Su; Pei-Chih Wu; Chuan-Yi Tang; Chun-Tien Chang; Shi-Hwei Liu; Margaret Dah-Tsyr Chang
Journal:  BMC Bioinformatics       Date:  2006-01-25       Impact factor: 3.169

2.  Sequence-specific backbone resonance assignments and microsecond timescale molecular dynamics simulation of human eosinophil-derived neurotoxin.

Authors:  Donald Gagné; Chitra Narayanan; Khushboo Bafna; Laurie-Anne Charest; Pratul K Agarwal; Nicolas Doucet
Journal:  Biomol NMR Assign       Date:  2017-03-07       Impact factor: 0.746

3.  Selective abolition of pancreatic RNase binding to its inhibitor protein.

Authors:  Kapil Kumar; Michael Brady; Robert Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-17       Impact factor: 11.205

Review 4.  Using NMR spectroscopy to elucidate the role of molecular motions in enzyme function.

Authors:  George P Lisi; J Patrick Loria
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2015-12-07       Impact factor: 9.795

Review 5.  Eosinophil-derived neurotoxin / RNase 2: connecting the past, the present and the future.

Authors:  H F Rosenberg
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

6.  High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.

Authors:  Demetres D Leonidas; Gayatri B Chavali; Nikos G Oikonomakos; Evangelia D Chrysina; Magda N Kosmopoulou; Metaxia Vlassi; Claire Frankling; K Ravi Acharya
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

7.  The flexibility of a distant loop modulates active site motion and product release in ribonuclease A.

Authors:  Nicolas Doucet; Eric D Watt; J Patrick Loria
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

8.  Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.

Authors:  Milica M Grozdanovic; Christine B Doyle; Li Liu; Brian T Maybruck; Mark A Kwatia; Nethaji Thiyagarajan; K Ravi Acharya; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2020-01-23       Impact factor: 10.793

9.  Crystal structure of Onconase at 1.1 Å resolution--insights into substrate binding and collective motion.

Authors:  Daniel E Holloway; Umesh P Singh; Kuslima Shogen; K Ravi Acharya
Journal:  FEBS J       Date:  2011-09-28       Impact factor: 5.542

10.  Crystal structure of human angiogenin with an engineered loop exhibits conformational flexibility at the functional regions of the molecule.

Authors:  Nethaji Thiyagarajan; K Ravi Acharya
Journal:  FEBS Open Bio       Date:  2012-12-26       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.